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Objective: Computed tomographic angiography (CTA) is currently the most commonly used technique for postoperative
surveillance to detect endoleaks after endovascular stent graft repair of abdominal aortic aneurysms. We have evaluated
the efficacy of duplex ultrasound scan with the addition of an ultrasound scan contrast agent in documenting endoleaks
and compared these results with CTA.
Methods: Conventional duplex ultrasound scan with color Doppler imaging (CDI) was first done as part of routine
postoperative surveillance. After the CDI study, a 1-mL bolus of ultrasound scan contrast was given via an antecubital
vein, followed by a 5-mL flush with normal saline solution. The duplex ultrasound scan evaluation of the stent graft was
repeated once the contrast agent was circulating throughout the blood pool, with tissue harmonic imaging to optimize
visualization of the contrast agent. Status of the stent graft, the presence or absence of any endoleak, and whether these
endoleaks were graft related (group I) or arterial branch related (group II) were recorded. Findings were compared with
CTA studies done within a 2-week period of the ultrasound scan examination.
Results: Twenty patients were evaluated, 18 with modular stent grafts and two with unibody bifurcated stent grafts.
Patients had a mean age of 74.5 7.6 years; 19 were male, with only one female. All stent grafts remained widely patent
with normal aortoiliac flow hemodynamics. Duplex ultrasound scan with contrast identified all eight of the endoleaks
seen with CTA and was able to determine whether they were group I or group II leaks. In two patients, ultrasound scan
with contrast detected small endoleaks at the proximal graft attachment site, with extravasation of contrast into the
aneurysm sac during systole. These endoleaks were not seen with CTA but were confirmed with conventional angiography
at the time of endovascular closure. Standard duplex ultrasound scan with CDI failed to identify four of the 10 endoleaks
in patients with technically difficult conditions.
Conclusion: Duplex ultrasound scan, when used with an intravenously administered ultrasound scan contrast agent in the
noninvasive follow-up of patients with aortic stent grafts, appears to provide good sensitivity to the presence and type of
endoleaks, even in patients with technically difficult conditions not amenable to conventional duplex ultrasound scan
with CDI. (J Vasc Surg 2003;37:381-5.)
During the past decade, the technology and techniques
for the percutaneous placement of aortoiliac bypass grafts
supported by a framework of metallic stents have been
developed, and these stent grafts are now widely used for
the treatment of abdominal aortic aneurysms. The opti-
mum stent graft design is not yet known, and one compli-
cation common to all stent graft designs is the postopera-
tive leakage of blood flow into the residual aneurysm sac
(endoleak).1 The natural history and clinical significance of
endoleaks is not yet completely known, and until more
definitive data are available, detection and, in many cases,
repair of these endoleaks are important.2-4
The most commonly used technique at present for the
follow-up of aortic stent grafts and the detection of en-
doleaks is computed tomographic angiography (CTA).
Duplex ultrasound scan with color Doppler imaging (CDI)
offers several potential advantages over CTA for stent graft
follow-up in that it is noninvasive, widely available, and
relatively inexpensive. It has the disadvantages, however, of
being operator dependent and less sensitive to the detec-
tion of endoleaks than CTA.5-9 The use of intravenously
administered ultrasound scan contrast agents in echocardi-
ography has led to an increased sensitivity in the detection
of wall motion abnormalities and better endocardial delin-
eation.10 The increased ultrasonic reflectivity of these
agents circulating in the blood pool may also provide better
sensitivity for the detection of other vascular anomalies,
such as endoleaks. We report our early results of postoper-
ative duplex ultrasound scan surveillance of aortic stent
grafts with the use of an ultrasound scan contrast agent, and
we compare these results with CTA.
METHODS AND MATERIALS
This study was approved before initiation by the Wil-
liam Beaumont Hospital Human Investigation Committee
(Institutional Review Board) for an enrolment of 20 pa-
tients. Before enrollment, all patients signed the institu-
tionally approved informed consent statement. Patients
who had a percutaneously placed aortobiiliac stent graft for
infrarenal aortic aneurysmal disease were considered eligi-
ble for the study. As part of routine postoperative surveil-
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lance at 1, 3, 6, and 12 months, a standard aortic duplex
ultrasound scan examination (LOGIQ700, GE, Milwau-
kee, Wis), with CDI and spectral Doppler velocity measure-
ments, was done in the ICAVL-accredited outpatient vas-
cular laboratory by a registered vascular technologist (PJB).
The operator was blinded to the results of any previous
ultrasound scans and of any prior angiographic or CTA
studies. The aorta was scanned in long axis and in cross-
sectional views from the level of the diaphragm distally to
below the attachment sites of the iliac limbs of the stent
graft. Residual aneurysm sac size was measured in both
anterior-posterior and transverse dimensions at its widest
point, and arterial flow hemodynamics were documented
throughout the stent graft with spectral Doppler velocity
measurements. CDI was adjusted for optimum sensitivity
to slow flows, and the entire stent graft and aneurysm sac
were scanned to detect any endoleaks that might be
present. Any suspected endoleak was further documented
for flow characteristics with spectral Doppler velocities.
After completion of the standard aortic postoperative
scanning protocol, a 1-mL bolus of ultrasound scan con-
trast agent (Optison, Mallinckrodt, St Louis, Mo) was
given via injection into an antecubital vein, followed by a
flush of 5 mL of normal saline solution. The contrast agent
was allowed to circulate in the blood pool for approxi-
mately 1 minute, and then the aortic stent graft and aneu-
rysm sac were again scanned from the level of the dia-
phragm to below the iliac limb attachment points in
longitudinal and cross-sectional scanning modes. For scan-
ning with the contrast agent, the duplex ultrasound scan
system was set up to take advantage of the acoustic prop-
erties of the agent with tissue harmonic imaging on the
basis of digitally coded and processed transmit-receive
pulse sequences. The entire examination was tape recorded
for later review and analysis, and the ultrasound scan oper-
ator’s real-time impressions were recorded as well. The
determination of the presence or absence of endoleaks for
duplex ultrasound scan with contrast was based primarily
on the real-time B-mode image data, with spectral Doppler
recordings taken at sites of suspected endoleaks.
Any endoleaks that were seen with duplex ultrasound
scan were classified as being related to the stent graft itself
(group I), at either the proximal or distal attachment sites
or at any graft module junctions or secondary to patent
aortic branch vessels (group II), such as the inferior mes-
enteric artery or lumbar arteries, which showed collateral
filling and back-bleeding into the aneurysm sac. An en-
doleak was classified as indeterminate if it could not be
definitively identified as being in group I or group II. CTA
was done after a standard stent graft protocol, with delayed
dual spiral imaging before and after (60-second and 120-
second delays) a 175-mL to 200-mL bolus of intravenous
contrast. Multiple axial images were taken with a 2-mm to
3-mm slice thickness with a 1.5-mm reconstruction algo-
rithm throughout the region of interest. All CTA studies
done within a 2-week period of the duplex ultrasound scan
were read independently for the presence or absence of
endoleaks and, if present, classified in the same manner as
those seen with ultrasound scan.
RESULTS
During the study period from January to December
2001, 69 aortic stent grafts were placed. There were 63
male patients and six female patients, and the average
patient age was 72.6  8.7 years (range, 58 to 87 years).
Mean aneurysm size was 5.6  0.9 cm, and this was not
different for male versus female patients. Sixty-four of the
grafts had a modular design, and five grafts had a unibody
bifurcated design. Endoleaks were detected at some time
during placement or follow-up of these grafts in 26% of
cases (18 patients).
Twenty patients were evaluated in the vascular labora-
tory after the ultrasound scan contrast agent protocol for
this study. Ten of these patients were selected at random,
and 10 were selected because of the technical difficulty of
the conventional duplex ultrasound scan from patient body
habitus or presence of bowel gas. There were 19 male
patients and one female patient; mean patient age was
74.5 7.6 years (range, 65 to 86 years). Eighteen of these
patients had a modular graft design, and two patients had
had a unibody bifurcated graft placed. Mean aneurysm size
was 5.8 0.8 cm at the time of graft placement. Timing of
the follow-up examination ranged from 1 to 12 months
after graft placement, with a mean follow-up time of 5.3
3.0 months.
Comparisons of conventional duplex ultrasound scan
with CDI (ultrasound CDI), duplex ultrasound scan with
contrast (ultrasound contrast), and CTA results are shown
in Tables I and II. ultrasound CDI identified six endoleaks
and was able to classify three of them into group I and one
into group II; two endoleaks were noted, but their origin
was not able to be definitively determined. CTA identified
eight endoleaks and classified two of them into group I and
three into group II; three additional posterior sac endoleaks
were seen, but their origin was not clearly identified. Ultra-
sound scan with contrast identified all eight endoleaks seen
with CTA and was able to classify all of them; four were
seen to be in group I, and four were seen to be in group II.
Table I. Correlation of duplex ultrasound scan and CTA
findings
(–) Leak () Leak
Ultrasound CDI 14 6
Ultrasound contrast 10 10
CTA 12 8
Table II. Classification of detected endoleaks as group I
or group II
Group I Group II Indeterminate
Ultrasound CDI 3 1 2
Ultrasound contrast 6 4 0
CTA 2 3 3
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For endoleaks seen with CTA and ultrasound scan contrast
that were able to be classified, there was complete agree-
ment as to group I versus group II. All four of the group I
endoleaks seen with ultrasound contrast and with CTA
were also confirmed with angiography during endovascular
repair. Two of the four group II endoleaks identified with
ultrasound contrast and CTA underwent endovascular re-
pair with angiographic confirmation of their presence and
site of origin. The other two group II endoleaks seen with
both techniques are being followed but have not as yet
been believed to warrant repair, and no angiographic cor-
relation is available.
In addition, two small group I endoleaks were seen
with ultrasound contrast, with extravasation of a thin streak
of contrast agent at the proximal attachment site of the
grafts into the aneurysm sac. Both of these endoleaks were
later confirmed with contrast angiography during endovas-
cular repair.
DISCUSSION
The presence of leakage of blood flow into the residual
aneurysm sac, or endoleak, remains the most common
complication after stent graft repair of abdominal aortic
aneurysms. Reported series show a postoperative rate of
endoleaks between 10% and 45%, with persistent endoleaks
seen at 3 years of follow-up in 25% of patients.4,11,12
Although the natural history and clinical consequences of
endoleaks are not fully known, the presence of an endoleak
may place the aneurysm sac under arterial pressure and
increase the risk of rupture.2,13-16 Because endoleaks may
occur at any time after stent graft placement, life-long
surveillance is necessary in these patients. At present, the
most commonly used technique for surveillance for en-
doleak detection is CTA with delayed helical imaging tech-
niques after the bolus injection of contrast. Duplex ultra-
sound scan makes a theoretically appealing alternative to
CTA for postoperative surveillance because of its noninva-
sive nature, its widespread availability, and the fact it is a
relatively inexpensive technology.
The primary disadvantages to conventional duplex ul-
trasound scan with CDI are the operator dependence of
ultrasound scan studies generally, technically inadequate
stent graft studies that occur in approximately 10% to 15%
of patients, and the lack of sensitivity to small or slow flow
endoleaks, with overall accuracy in endoleak detection re-
ported between 75% and 90%.6-9 If CDI gain is increased to
try to increase the sensitivity to slow flow, a significant
“flash” artifact results from detection of the pulsatile mo-
tion of the metallic struts supporting the stent graft and
leads to a high rate of false-positive studies. To attempt to
overcome these limitations, we have investigated the use of
duplex ultrasound scan with an intravenously administered
ultrasound scan contrast agent.
Ultrasound contrast agents are typically microbubbles
of a perfluorocarbon gas encapsulated within a thin lipid or
human albumin shell for stability while circulating in the
blood pool. The microbubbles typically have a range of
diameters from 2 to 5 microns, with a suspension of ap-
proximately 5  108 microbubbles per mL of fluid. The
microbubbles slowly dissolve as the shell is metabolized,
and the perfluorocarbon gas is eliminated through the
lungs with normal respiration; a 1-mL bolus injection of
the contrast agent will allow approximately 3 to 4 minutes
of enhanced visualization and scanning time. At diagnostic
ultrasound scan frequencies of 3 to 5 MHz, the reflectivity
of the microspheres is much greater than that of whole
blood, increasing signal strength for imaging 100 to 1000
times.17 An additional advantage of the contrast agent is
the nonlinear behavior when insonated with the ultrasound
scan beam; the returning signal has strong components of
both the fundamental transmitted frequency and the sec-
ond harmonic, at twice the transmitted frequency.18,19
This allows imaging with the technique of tissue harmon-
ics, which further suppresses returning echoes from station-
ary structures and effectively enhances the blood flow signal
in the image (Fig 1). As applied to the surveillance of stent
grafts, it is hypothesized that increased ultrasound scan
signals will arise from wherever blood is flowing, including
the aneurysm sac in the case of an endoleak, with suppres-
sion of the stationary echo from the thrombus within the
sac with tissue harmonic imaging to improve the contrast
between these two in the resulting image (Fig 2).
Side effects of the contrast agent are minimal and occur
rarely. There is the potential for hypersensitivity or an
allergic reaction to the albumin shell of the contrast agent,
which can be treated with antihistamines. Exclusion criteria
for this study to obtain Institutional Review Board approval
(on the basis of recommendations for the use of the ultra-
sound scan contrast agent) included patients with known
cardiac right-to-left shunts or pulmonary disease, known
liver disease, or known allergy or hypersensitivity to albu-
min; women had to be postmenopausal to participate. No
patients in this study were excluded from consideration on
the basis of these factors, and no patients had any reactions
or other side effects related to the contrast agent.
The results of this study appear to support these hy-
potheses and indicate that an ultrasound scan contrast
agent is efficacious in detection of endoleaks. All endoleaks
seen with ultrasound scan contrast were readily identified
with real-time B-mode (harmonic) imaging alone; spectral
Doppler confirmed the presence of flow at these sites but
was not believed to add any additional diagnostic informa-
tion. In comparison with CTA, all eight endoleaks seen
with CTA were identified with duplex ultrasound scan with
contrast. In these eight patients, ultrasound contrast was
also able to classify the origin of the endoleak as group I or
group II, and CTA did not definitively identify the source
in three patients. In addition, two other patients were
noted with ultrasound scan to have small group I endoleaks
at the proximal attachment site that were not seen with
CTA. A postoperative stent graft protocol was followed for
all CTA studies done, which included delayed helical imag-
ing after contrast administration and a thin, 2-mm to
3-mm, slice thickness.20 Review of the CTA studies showed
them to be of good technical quality, but the presence of
metallic strut flare artifacts in the images at the site of these
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two small endoleaks was seen and these likely obscured
imaging of any extravasated contrast (Fig 3).
Conventional duplex ultrasound scan with CDI only
identified six of 10 endoleaks. The four endoleaks not seen
were all in patients with conditions that were technically
difficult to image and who were intentionally chosen for
this study, a selection bias which will make the standard
duplex ultrasound scan results appear worse than those of
other series that studied unselected patients. These results,
however, do emphasize the limitations of conventional
duplex ultrasound scan discussed previously and show that
they can be overcome with the use of a contrast agent.
Fig 1. A, Cross-sectional duplex ultrasound scan image of main body of aortic stent graft with no evidence of endoleak
with ultrasound scan contrast with tissue harmonic imaging. Contrast agent in blood pool provides strong ultrasound
scan signal and appears bright on image while surrounding aneurysm sac and soft tissue signals are suppressed to
increase contrast. Mesenteric vessels outside aneurysm sac are also clearly seen. B, Cross-sectional duplex ultrasound
scan image of iliac limbs of aortic stent graft with no evidence of endoleak with ultrasound scan contrast with tissue
harmonic imaging. Contrast agent in blood pool provides strong ultrasound scan signal and appears bright on image
while surrounding aneurysm sac and soft tissue signals are suppressed to increase contrast.
Fig 2. Cross-sectional duplex ultrasound scan image of main
body of aortic stent graft with small proximal group I endoleak
with ultrasound scan contrast with tissue harmonic imaging. In
diastolic phase of cardiac cycle, ultrasound scan signal from within
stent is diminished so that stent itself and aneurysm sac are seen.
Contrast agent extravasated into aneurysm sac at proximal attach-
ment site has persistent echogenicity and is seen as series of bright
echoes in 9 to 10 o’clock position relative to stent. Fig 3. CTA showing metallic artifact near proximal stent attach-
ment site that may obscure any small endoleak localized to that
region of graft.
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In an earlier report comparing the use of an ultrasound
scan contrast agent with CTA for the detection of en-
doleaks in 18 patients, McWilliams et al21 found that there
was poor sensitivity of duplex ultrasound scan with conven-
tional CDI (33%), whereas contrast-enhanced CDI identi-
fied all endoleaks seen with CT scan for a 100% sensitivity.
They also noted a large number of additional (false?) posi-
tive contrast-enhanced ultrasound scan studies without
endoleaks noted with CTA (positive predictive value, 33%),
without further independent direct confirmation of the
presence of a true endoleak. Although they reported sec-
ondary evidence of possible endoleak in half of these cases,
the false-positive rate with contrast was significantly higher
than for conventional CDI and likely caused by color
Doppler image blooming artifacts that are markedly in-
creased in intensity in the presence of a contrast agent. In
this study, we had the advantage of using digitally encoded
tissue harmonic imaging, which does not rely on CDI
techniques and which effectively suppresses many of the
artifacts associated with duplex ultrasound scan while en-
hancing the strength of the echo received from flowing
blood, and this may account for the lack of any false-
positive studies in our own experience.
Our preliminary experience with an ultrasound scan
contrast agent and tissue harmonic imaging for surveillance
of aortic stent grafts has shown apparent improved sensitiv-
ity to the detection of endoleaks. All types of endoleaks,
related directly to the graft or secondary to branch vessels,
were detected with 100% sensitivity. Small or slow flow
endoleaks were not a limitation as well, and duplex ultra-
sound scan with contrast detected two of these endoleaks
that were not seen with CTA. This technique was noted to
be relatively free of artifacts that have limited the accuracy
of conventional duplex ultrasound scan with CDI. Tissue
harmonic imaging appeared less susceptible to the presence
of patient obesity or bowel gas in that four endoleaks were
identified with ultrasound scan contrast in such patients but
were not seen with conventional ultrasound scan with CDI.
System default settings for harmonic imaging of the con-
trast agent were used, and this technique may also help
eliminate some of the operator dependence in acquiring
technically adequate ultrasound scans. In addition, imaging
with contrast may make it easier to evaluate the position of
the proximal attachment site of the stent graft relative to an
anatomic reference point, such as the origin of the renal
arteries, because imaging of these vessels is also enhanced
with the contrast agent.22 These results, however, should
be considered preliminary, and further evaluation of the
efficacy of ultrasound scan contrast agents needs to be done
on larger series of consecutive unselected patients before
routine clinical use can be advocated.
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